Dr Reddy's Laboratories shares declined by 2.08% to trade at ₹1,155.50 at 09:36 AM on Tuesday, placing it among the top losers on the Nifty 50 index. According to Moneycontrol analysis on August 3, 2026, the decline reflects a bearish sentiment affecting the pharmaceutical company's stock performance. The latest market data shows continued selling pressure with the stock trading below its 52-week high of ₹2,174.70 and above its 52-week low of ₹1,745.00.
Dr Reddy's Laboratories has demonstrated mixed financial performance over the past five fiscal years on a consolidated basis. Revenue increased significantly from ₹21,545.20 crore in 2022 to ₹33,700.20 crore in 2026, representing a substantial 56.41% growth over the period. However, Net Profit showed volatility, rising from ₹2,112.20 crore in 2022 to a peak of ₹5,703.50 crore in 2025, before decreasing to ₹4,144.20 crore in 2026. Earnings Per Share (EPS) peaked at ₹335.22 in 2024 before falling to ₹50.41 in 2026, partly due to a stock split from a face value of ₹5 to ₹1 in October 2024.
In the recent consolidated quarterly results for the period ending June 2026, revenue declined to ₹8,099.80 crore from ₹8,572.10 crore in the quarter ending June 2025, representing a 5.51% decrease. Net profit dropped significantly to ₹434.80 crore from ₹1,409.70 crore in the corresponding quarter of the previous year, marking a substantial 69.15% decline. EPS stood at ₹5.33 for the quarter ending June 2026.
As of March 2026, Dr Reddy's Laboratories' consolidated total assets stood at ₹58,123 crore, including current assets of ₹30,179 crore and fixed assets of ₹22,043 crore. Total liabilities were also ₹58,123 crore, with current liabilities amounting to ₹16,747 crore. The consolidated cash flow from operating activities was ₹5,673 crore in the year-ending March 2026, while investing activities resulted in a net outflow of ₹6,549 crore.
Dr Reddy's Laboratories announced a final dividend of ₹8.00 per share (800%) with an effective date of July 10, 2026. The company also executed a stock split from a face value of ₹5 to ₹1 on October 28, 2024. Prior to that, a bonus issue of 1:1 was announced on May 31, 2006.
